Skip to main content
. 2020 Mar 12;139(6):1025–1044. doi: 10.1007/s00401-020-02138-6

Fig. 4.

Fig. 4

Role of p.P522R in the interrelationship between amyloid pathology, neurodegeneration, and cognitive decline. a Predicted relationship between Aβ1-42 levels in CSF and pTau181 levels in CSF for p.P522R carrier and non-carrier. Red shaded areas indicate significant differences between p.P522R carrier and non-carrier. Significance is based on the estimation of simultaneous confidence intervals that consider the statistical testing at multiple CSF levels. b Predicted relationship between Aβ1-42 levels in CSF total tau levels in CSF for p.P522R carrier and non-carrier. Red shaded areas indicate significant differences between p.P522R carrier and non-carrier. Significance is based on the estimation of simultaneous confidence intervals that consider the statistical testing at multiple CSF levels. c Results from a structural equation model assessing whether the effect of p.P522R on the cognitive change in the normalized MMSE (range 0–100) is mediated Abeta1-42 levels or pTau181 levels in CSF. The model showed a good fit to the data (Model fit indices: RMSEA = 0.017, CFI = 0.996, SRMR = 0.060, see supplementary text 6.4, online resource)